Cantor Fitzgerald cut shares of Soleno Therapeutics (NASDAQ:SLNO – Free Report) from an overweight rating to a hold rating in a report issued on Monday morning, Marketbeat Ratings reports. Cantor Fitzgerald currently has $53.00 price objective on the stock, down from their prior price objective of $123.00. A number of other equities research analysts have […]